Sword and Shield Pharma Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2019. For the quarter, revenue from operations was INR 2.040 million against INR 0.070 million a year ago. Profit for the period was INR 1.837 million against loss of INR 0.094 million a year ago. Diluted EPS was INR 0.36 against LPS of INR 0.02 a year ago. For nine months, revenue from operations was INR 2.271 million against INR 0.118 million a year ago. Profit for the period was INR 1.244 million against loss of INR 0.678 million a year ago. Diluted EPS was INR 0.24 against LPS of INR 0.13 a year ago.